Buflomedil in a hamster skin flap model
Animal study · male 10-week-old Syrian golden hamsters; McFarlane skin flap model [1]
Male Syrian golden hamsters in the McFarlane skin flap model received Buflomedil intraperitoneally before skin flap preparation and postoperatively. The percentage of viable areas did not differ among the control, Buflomedil, and pentoxifylline groups.
| Endpoint | Reported result | Reference |
|---|---|---|
| percentage of viable area (%VA); on the seventh post-operative day | Reported result 3 mg/kg/day of buflomedil; on the seventh post-operative day: there was no difference in the percentage of viable areas among the control, buflomedil, and pentoxifylline groups (50.7, 52.9, and 47.0, respectively). | [1] |
Conditions shared by the study groups
- Route
- intraperitoneally
- Treatment course
- 1 hour before skin flap preparation and for 7 days post-operatively at 12-hour intervals
- Vehicle
- 0.9% NaCl
| Group / dose | Comparator | Observed result | Reference |
|---|---|---|---|
| Buflomedil 3 mg/kg/day | The control group received 0.1 ml of vehicle (C, 0.9% NaCl) | 3 mg/kg/day of buflomedil; on the seventh post-operative day: there was no difference in the percentage of viable areas among the control, buflomedil, and pentoxifylline groups (50.7, 52.9, and 47.0, respectively). | [1] |
- Buflomedil 3 mg/kg/day
- Model: male 10-week-old Syrian golden hamsters; McFarlane skin flap model
- Reported limits: Removed after verification: value.
Methods and source locations
Compound reported in the paper: Buflomedil
The paper names Buflomedil without stating the salt or form; not verified as the hydrochloride form supplied as A11737. No dose conversion or lot validation.
MATERIALS AND METHODS (S1, S3, S4, S11); MATERIALS AND METHODS > Parameters Evaluated > Percentage of viable skin flap area (%VA) (S22); RESULTS (S35)
percentage of viable area (%VA); on the seventh post-operative day: percentage of viable area (%VA); on the seventh post-operative day; comparator: The control group received 0.1 ml of vehicle (C, 0.9% NaCl) — MATERIALS AND METHODS (S3); MATERIALS AND METHODS > Parameters Evaluated > Percentage of viable skin flap area (%VA) (S22); RESULTS (S35)
Buflomedil 3 mg/kg/day · MATERIALS AND METHODS (S3, S4); MATERIALS AND METHODS > Parameters Evaluated > Percentage of viable skin flap area (%VA) (S22); RESULTS (S35)